Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematoma.
Fink
J N
JN
Stroke Division, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. jfink@caregroup.harvard.edu
McAuley
D L
DL
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D002540:Cerebral Cortex / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D020766:Intracranial Embolism / Q000175:diagnosis / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D012307:Risk Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy*
D000925:Anticoagulants; D006493:Heparin